Aldosterone-Producing Adrenocortical Carcinoma with Co-Secretion of Cortisol and Estradiol: A Case Report

Authors

Keywords:

adrenal cancer, adrenocortical carcinoma, hyperaldosteronism, hypertension

Abstract

Aldosterone-producing adrenocortical carcinoma comprises less than 7% of all functioning adrenocortical carcinomas. We report a rare case of adrenocortical carcinoma with a clinical picture of primary aldosteronism and subclinical Cushing’s syndrome and feminization. Complete surgical resection normalized blood pressures and aldosterone, cortisol and estradiol levels. Long-term monitoring is recommended with imaging and hormonal evaluation used as tumor markers for recurrence.

Downloads

Download data is not yet available.

Author Biographies

Karen Lazaro, The Medical City

Fellow-in-training, Section of Endocrinology, Diabetes and Metabolism, The Medical City

Perie Adorable-Wagan, The Medical City

Consultant, Section of Endocrinology, Diabetes and Metabolism

References

United States. National Cancer Institute. Biometry Branch, Young JL, Cutler SJ, Connelly RR. Third national cancer survey: Incidence data. Bethesda, Md. : US Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, 1975.

Ng L, Libertino JM. Adrenocortical carcinoma: Diagnosis, evaluation and treatment. J Urol. 2003;169(1):5–11. PMID: 12478091. https://doi.org/10.1097/01.ju.0000030148.59051.35.

Seccia TM, Fassina A, Nussdorfer GG, Pessina AC, Rossi GP. Aldosterone-producing adrenocortical carcinoma: An unusual cause of Conn’s syndrome with an ominous clinical course. Endocr Relat Cancer. 2005;12(1):149–59. PMID: 15788646. https://doi.org/10.1677/erc.1.00867.

Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5): 1889-916. PMID: 26934393. https://doi.org/10.1210/jc.2015-4061.

Young WF Jr. Endocrine Hypertension. William's Endocrinology, 13th edition. Chapter 16. http://medical.iauyazd.ac.ir/files/MEDICINE/Endocrinology/Williams%20Textbook%20of%20Endocrinology%20%202016/16%20Endocrine%20Hypertension.pdf.

Fassnacht M, Kroiss M, Allolio B. Update in adrenocortical carcinoma. J Clin Endocrinol Metab. 2013;98(12):4551–64. PMID: 24081734. https://doi.org/10.1210/jc.2013-3020.

Allolio B, Fassnacht M. Clinical review: Adrenocortical Carcinoma: Clinical Update. J Clin Endocrinol Metab. 2006; 91(6):2027-37. PMID: 16551738. https://doi.org/10.1210/jc.2005-2639.

Berruti A, Baudin E, Gelderblom H, et al. Adrenal cancer: ESMO Clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23 (Suppl 7): vii131–8. PMID: 22997446. https://doi.org/10.1093/annonc/mds231.

Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol. 1989;13(3):202–6. PMID: 2919718.

Published

2018-05-21

How to Cite

Lazaro, K., & Adorable-Wagan, P. (2018). Aldosterone-Producing Adrenocortical Carcinoma with Co-Secretion of Cortisol and Estradiol: A Case Report. Journal of the ASEAN Federation of Endocrine Societies, 33(1), 57. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/451

Issue

Section

Case Reports